LifeArc collaboration helps to advance a potential new cancer drug towards the clinic
Making our unique ULK inhibitors available as tools for the academic community has helped to reignite interest…
Making our unique ULK inhibitors available as tools for the academic community has helped to reignite interest…
LifeArc’s scientists have been working on a fresh approach to drug discovery, using a parallel high-throughput application…
Technology transfer is a highly trained and multidisciplinary scientific endeavour, providing the crucial link between academic research…
While the development of COVID-19 vaccines has garnered much attention, scientists have also been looking at repurposed…
A team from LifeArc and Göttingen University has developed a new approach to intervene in early-stage treatment…
In 2020 the UK Government, supported by UK Research and Innovation and the National Institute for Health…
Our technology transfer team has helped the Medical Research Council (MRC), a founder in PepGen, to advance…
While much attention in the race for treatments for Covid-19 has been on the development of new…
A project by an industrial placement student led to Virtual Reality becoming a powerful tool for drug…